Increased cost effectiveness with nesiritide vs. milrinone or dobutamine in the treatment of acute decompensated heart failure.

Congestive heart failure (Greenwich, Conn.)

Volumn 11, Issue 6, 2005, Pages 311-314

  Scroggins, Nancy ^a   Edwards, Michelle ^a   Delgado 3rd , Reynolds ^a  

^a ST LUKE S EPISCOPAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; DOBUTAMINE; MILRINONE;

ACUTE DISEASE; ARTICLE; COHORT ANALYSIS; COMPARATIVE STUDY; CONGESTIVE HEART FAILURE; COST BENEFIT ANALYSIS; COST OF ILLNESS; DRUG COST; ECONOMICS; FEMALE; FOLLOW UP; HOSPITAL COST; HOSPITALIZATION; HUMAN; MALE; RETROSPECTIVE STUDY; RISK ASSESSMENT; TREATMENT OUTCOME;

ACUTE DISEASE; COHORT STUDIES; COST OF ILLNESS; COST-BENEFIT ANALYSIS; DOBUTAMINE; DRUG COSTS; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE, CONGESTIVE; HOSPITAL COSTS; HUMANS; MALE; MILRINONE; NATRIURETIC PEPTIDE, BRAIN; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 33644874957     PISSN: 15275299     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1527-5299.2005.04359.x     Document Type: Article

References (0)